A 45-year-old woman presents with a 6-month history of symmetric eruption on her cheeks, eyelids, and chin. On examination, she has multiple discrete, firm, dome-shaped papules with a reddish-brown to yellow-brown hue. Diascopy reveals an apple-jelly appearance. There are no comedones, pustules, or telangiectasias. Histopathology shows dermal non-caseating epithelioid granulomas. The condition marked **B** in the diagram is suspected. Which of the following is the most appropriate first-line management for this condition?
A. Oral doxycycline 100 mg twice daily for 3–6 months
B. Oral isotretinoin 0.5 mg/kg/day for 4–6 months
C. Topical betamethasone dipropionate 0.05% twice daily
D. Intralesional triamcinolone acetonide monthly
Explanation
Why Oral doxycycline 100 mg twice daily for 3–6 months is right
Granulomatous rosacea (including lupus miliaris disseminatus faciei) is characterized by monomorphic, firm, dome-shaped papules with granulomatous histopathology and absence of pustules or telangiectasias. The clinical anchor—discrete, firm papules with apple-jelly diascopy appearance and non-caseating granulomas—defines this condition. Tetracycline-class antibiotics (doxycycline 100 mg twice daily or minocycline 100 mg daily) are the established first-line treatment for 3–6 months, leveraging both antimicrobial and anti-inflammatory properties. This regimen reduces inflammation, prevents scarring, and achieves remission in most patients (Bolognia Dermatology 5e; Plewig Acne and Rosacea 4e).
Why each distractor is wrong
Topical betamethasone dipropionate 0.05% twice daily: Topical corticosteroids are contraindicated and worsen rosacea. They may provide short-term suppression but perpetuate the condition and increase risk of steroid-induced rosacea. This is explicitly avoided in granulomatous rosacea management.
Oral isotretinoin 0.5 mg/kg/day for 4–6 months: Isotretinoin is reserved for resistant or severe scarring disease after failure of first-line tetracyclines, not as initial therapy. It carries significant teratogenicity and requires strict monitoring, making it inappropriate as first-line.
Intralesional triamcinolone acetonide monthly: Intralesional steroids are not standard first-line therapy for granulomatous rosacea and may worsen the condition. Systemic tetracyclines address the underlying inflammatory and granulomatous process more effectively.
High-YieldNEET PG
Granulomatous rosacea = monomorphic firm papules + apple-jelly diascopy + non-caseating granulomas → treat with tetracyclines (doxycycline/minocycline), NOT steroids.
Bolognia Dermatology 5e; Plewig Acne and Rosacea 4e
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
